Maine's Cannabis 'Gray Market' Is Growing Because the Regulators Can't Keep Up

The 1,500-caregiver question

Every operator I have spoken to in the last six months has, at some point, gestured at the same problem: Maine's regulated adult-use and medical cannabis system is technically a closed market, but in practice, the majority of the cannabis moving through the state moves through channels the Office of Cannabis Policy does not meaningfully inspect.

The licensed adult-use and medical retail establishment population is real and growing. As of December 31, 2025 (OCP 2025 Annual Report), the OCP's public roster counts 343 active adult-use establishments: 187 cannabis retail stores, 78 cultivators, 81 products manufacturing facilities, and 4 testing facilities, plus 22 conditionally approved and 52 pending applications. These are the businesses most readers of this column have seen — the storefronts on Congress Street and Route 1, the cultivators with the warehouse setbacks, the brands that show up at the Portland Cannabis Convention.

But they are not the majority of the market. The OCP's 2025 MMCP Annual Report lists 1,539 active Maine caregivers as of December 31, 2025 (down 8.2% from 1,677 in 2024). A caregiver in Maine can register up to five qualifying patients, cultivate up to a documented patient count, and sell up to 12 pounds of prepared cannabis and 60 immature plants per year to their patient panel. That product is not counted in the OCP's retail excise data, and most of it does not appear in the agency's Metrc seed-to-sale tracking in the way retail store inventory does.

The 12-pound-per-caregiver number sounds small until you multiply it. 1,539 caregivers times 12 pounds equals 18,468 pounds — over 9 tons — of medical cannabis that, under the 2024 rules, can move into the patient network each year without passing through an adult-use dispensary. A non-trivial share of that product, according to four of the seven operators I interviewed, never stays inside the patient network at all.

What "gray market" actually means in Maine

When Maine operators use the phrase "gray market," they are not talking about the illicit trade that has always existed. They mean a specific, layered set of activities that sit in the legal space between fully licensed adult-use retail and the criminal prohibition that existed before 2016.

The first layer is caregiver overflow. A caregiver with a five-patient panel who consistently grows more than their patients need has, under the 2024 rules, two choices: destroy the surplus, or move it within the network through a patient-to-patient transfer that the OCP explicitly permits but does not centrally track. The OCP's compliance staff has historically not prioritized investigating these transfers. Several caregivers I spoke to described the transfers as a normal part of doing business, and one said, on background, "we don't even call it gray. The state wrote the rules, we follow the rules, and what the patient does with the cannabis after they leave our place is not something we're asked about."

The second layer is out-of-state delivery. A network of unlicensed online retailers — most of them operating from Massachusetts and from sovereign-flavored addresses in the broader Pacific Northwest — lists Maine consumers as customers, accepts payment in cryptocurrency or via money order, and ships via USPS or private carrier. A 2025 U.S. Postal Inspection Service operation in New England made a handful of seizures, but Maine has no parallel state-level enforcement priority. The OCP's enforcement memos published between 2023 and 2025 reference this trade in passing, but no Maine operator or patient I spoke to could identify a single prosecution for out-of-state delivery to a Maine address.

The third layer is the small retail store that operates inside a registered caregiver location. Maine's caregiver rules permit a registered patient to consume medical cannabis on the cultivator's premises if the cultivator holds a "safe consumption" endorsement. In practice, several caregivers have built out their properties into what look and function like dispensaries, complete with menus and a retail counter — but the OCP's dispensary license program is technically a separate license. Whether these locations are operating as disguised retail stores or as caregivers who happen to serve many patients in a setting that resembles retail is a question the OCP has not, to my knowledge, formally answered.

The compliance math that doesn't work

The OCP's enforcement problem is, at root, a math problem. The agency's biennial budget submission for fiscal years 2026-2027 requested 41 FTE compliance and enforcement positions, of which 38 were filled as of the most recent reporting period. That staff is responsible for:

• 343 active adult-use and medical establishments, including their annual renewals, on-site inspections, packaging and labeling reviews, and advertising complaints
• 1,539 active caregivers, most of whom the OCP sees only at registration and renewal
• ~$65 opt-in municipalities, each of which has its own zoning overlay that the OCP is expected to track
• An unknown but non-trivial number of online out-of-state operators and the patient complaints they generate
• The full adult-use application backlog, which as of early 2026 stood at roughly 90 days for new establishment licenses

Doing the division: 38 compliance staff against 1,882 licensees (343 establishments plus 1,539 caregivers) yields one compliance officer per 50 licensees. That ratio does not include the patient base, the application pipeline, the municipal coordination, or the gray-market activity. It is the ratio of staff to licensees, and it is already understaffed by the standards that other state cannabis regulators — Colorado, Oregon, Washington — publish in their annual reports. Those programs operate at ratios closer to one enforcement FTE per 20 licensees, and they do not have the caregiver complexity Maine does.

The OCP's response to this staffing pressure has been predictable. In the 2024 and 2025 enforcement reports, the agency explicitly prioritized "complaints-driven enforcement" — meaning that unless a member of the public files a complaint through the OCP's online portal, a particular licensee is unlikely to be inspected more than once every three to four years. The complaint-driven model is the right one for a fully-resourced agency, and the wrong one for an agency that has 1,500+ licensees and 38 staff.

What the operators say (on background)

I conducted seven interviews with Maine operators between February and May 2026, under standard background conditions: I would not name them, and they would not name the gray-market actors they described. Five of the seven are licensed adult-use or medical operators. One is a caregiver. One is a testing-facility operator.

Several themes emerged with enough consistency that I am comfortable reporting them as a pattern, even though I cannot attribute any single claim to a specific operator.

First, every operator I spoke to said the gray market is growing, not shrinking, and that the trend has accelerated since the 2024 caregiver rules were liberalized. Two operators estimated that the gray market now accounts for 25-35% of total cannabis sales in Maine by volume. The OCP's published adult-use excise revenue, which is roughly $18 million for the most recent fiscal year, is consistent with that estimate if you assume an average per-pound wholesale price of $1,500-$2,000 and a roughly 30% gray-market share.

Second, operators distinguished sharply between the caregiver overflow that exists because the program is structured the way it is, and the bad actors who are explicitly licensed to do one thing and do something else. The first group, they said, is a policy problem. The second is an enforcement problem. The operators I spoke to were almost universal in saying they would prefer stricter caregiver rules if stricter rules came with the staffing to enforce them. They are not getting either.

Third, the testing-facility operator I spoke to described a class of caregiver product submitted for voluntary compliance testing that consistently fails microbial and pesticide panels at a much higher rate than licensed adult-use product. The OCP does not require caregiver product to be tested, and most caregiver product is not. The operators I spoke to were not arguing for mandatory caregiver testing — that would be politically difficult to pass — but they were noting that the absence of testing creates a patient-safety question that the OCP's staffing and rule structure does not currently address.

What the OCP says, in its own words

It is worth pausing to credit what the OCP is doing well, because the agency's defenders — and there are several, including former director John Hudak's allies in the Maine cannabis trade press — are not wrong that the office is operating under conditions that would be difficult for any regulator.

The OCP's adult-use application portal, launched in 2021 and rebuilt in 2024, processes license applications at a pace that compares favorably with most other New England states. The agency's rule-making is transparent and well-documented. The OCP's annual report, published each March, is one of the more candid regulatory documents produced by a Maine state agency. Director Hudak, before his departure in 2025, was accessible to operators in a way that his counterparts in some other state agencies were not.

But the OCP's defenders have, in my view, a tendency to deflect the staffing question by pointing to the rule-making success. The two are not equivalent. A regulator that writes good rules and then cannot enforce them is not, on the whole, a successful regulator. It is a regulator that has set the stage for the gray market that operators describe.

What the gray market costs the legal market

The operators I spoke to were nearly universal in saying the gray market costs them money directly, in the form of patients who would otherwise be in their stores. The math is simple: a caregiver charging $150 per ounce to a patient panel of five is, from the patient's perspective, a more affordable source than an adult-use dispensary charging $200-$250 per ounce after the 10% retail excise and the 5.5% state sales tax. The patient is not choosing to break the law; they are choosing the legal option that costs them less.

The state also loses revenue. The OCP's most recent excise tax report shows roughly $18 million in adult-use excise collected in the most recent fiscal year. If the gray market is, as two operators estimated, 25-35% of the volume, the foregone excise is in the range of $4-7 million per year. That number is a rough estimate, and the OCP would not endorse it without a fuller audit, but it is directionally consistent with the operator interviews and with the gap between the per-capita cannabis consumption Maine would be expected to have and the per-capita consumption the excise data implies.

Most importantly, the gray market is hollowing out the political constituency for the legal market. Operators who do not see enforcement, who do not see competition reduced, and who do not see the gray market shrink year over year, are operators who will eventually stop investing in compliance. That is the trajectory the operators I spoke to described, and it is a trajectory the OCP's staffing structure is not currently positioned to reverse.

Three policies that would shrink the gray market

None of the operators I spoke to proposed prohibition, criminalization, or any retreat from the post-2016 framework. They proposed three specific changes that, in combination, would address the structural causes of the gray market rather than its symptoms.

First, raise the caregiver patient cap and clarify the rules around caregiver-to-caregiver transfers. The current five-patient cap was set in the early years of the medical program and reflects a model in which caregivers are intimately known to their patients. In a state with Maine's population distribution — rural, older, and spread across counties without a licensed dispensary in every town — the five-patient cap produces the patient-to-patient transfer network that operators describe. A modest increase to 15 or 20 patients per caregiver, combined with a Metrc-tracked transfer framework, would bring most of that activity into the OCP's view without criminalizing it.

Second, give the OCP a dedicated enforcement line item. The agency's biennial budget is set by the Department of Administrative and Financial Services and approved by the Legislature. The Governor's 2026-2027 budget submission did not include a dedicated enforcement line item. A statutory line item — say, 25 additional compliance FTEs funded through the agency's existing revenue streams — would close the gap between the OCP's mandate and its capacity. The cost would be roughly $2.5 million per year, well within the agency's current revenue.

Third, create a tiered operating license for caregiver networks that exceed the cap but fall short of full adult-use retail. Maine's licensing structure is binary: caregiver or adult-use. There is no middle tier. A network of caregivers that wants to operate at, say, 30 patients and 50 pounds of annual production has no legal path other than to apply for an adult-use dispensary license, which is a multi-year process with capital requirements that put it out of reach for most small operators. A middle tier — call it a "caregiver network license" — would bring these operators into the regulated system and generate tax revenue that is currently being lost.

What the data argues for, in one line

The Maine cannabis market is not failing. The legal market is growing, the OCP is writing good rules, the patient base is increasingly sophisticated, and the operators I spoke to are, almost without exception, building durable businesses. The gray market is not a sign that legalization was a mistake. It is a sign that the regulatory framework needs the staffing and the structure to keep up with the industry it is supposed to be regulating.

The OCP's defenders will say, fairly, that this is an unfair framing of an agency that has accomplished a great deal under difficult conditions. The agency's critics will say, also fairly, that the gray market is a predictable consequence of choosing rule-making over enforcement. The truth, as it usually is, is in the middle. The OCP needs more staff, the caregiver program needs modernization, and the licensing structure needs a middle tier. None of those changes requires a new law. All of them require a legislative session that takes the gray market seriously as a policy problem rather than as a footnote.